
The Drack Lab is excited to celebrate Dr. Tyler Rankin, who successfully defended his dissertation, “Advancing Therapeutic Development for Inherited Retinal Disorders,” on October 19, 2026, through the Interdisciplinary Graduate Program in Genetics at the University of Iowa!
Throughout his doctoral research, Tyler explored the complexities of inherited retinal diseases, investigating not only their underlying biology but also what it takes to move promising therapies from the laboratory toward clinical application.
His work investigated retinal dysfunction in Bardet–Biedl syndrome (BBS), including the potential of antioxidant supplementation and gene therapy to preserve retinal function. In collaboration with Dr. Lori Wallrath's laboratory at the University of Iowa, Tyler also helped develop a new mouse model of retinitis pigmentosa (RP), offering insights into how disruptions in a gene involved in RNA processing can lead to photoreceptor degeneration.
Recognizing that developing treatments is only part of the journey, Tyler also contributed to efforts to evaluate virtual reality-based mobility testing in collaboration with Dr. Jean Bennett's laboratory at the University of Pennsylvania. This approach seeks to measure functional vision in ways that reflect the challenges patients encounter in everyday life, with the potential to support future clinical trials. Together, his work across disease biology, therapeutic development, and functional vision assessment has helped advance the lab's efforts to bring new treatments closer to patients.
Tyler's contributions have extended beyond his individual projects. Through collaborations, scientific discussions, and a willingness to share his expertise, he has helped strengthen the research environment of the Drack Lab and contributed to new directions for our ongoing work.
Congratulations, Tyler! We are grateful for the curiosity, dedication, and enthusiasm you've brought to the lab and look forward to seeing where your work takes you next!